Novo GLP-1 pill OK’d in U.S. for heart disease risk (NVO:NYSE) Seeking Alpha FDA Approves Novo Nordisk’s Rybelsus Diabetes Pill to Reduce Heart Risk The Wall Street Journal First oral GLP-1 cuts cardiovascular risk by 14% – and it’s now FDA-approved New Atlas FDA approves Novo Nordisk’s oral semaglutide for cardiovascular (CV) risk reduction in adults with type 2 diabetes who are at …
Read More »Tag Archives: NVONYSE
GLP-1 drugs are linked to lower cancer risk: study (NVO:NYSE) – Seeking Alpha
GLP-1 drugs are linked to lower cancer risk: study (NVO:NYSE) Seeking Alpha Good News on GLP-1s and Cancer Risk, With One Exception MedPage Today Health Rounds: GLP-1 drugs linked to lower cancer risks Reuters GLP-1s Found to Reduce Cancer Risk in People With Obesity AJMC Weight loss jabs like Mounjaro linked to ‘silent cancer’ that is surging in under-50s, warn experts: ‘We need to …
Read More »Novo Nordisk continues to slip after outlook cut, obesity drug worries (NVO:NYSE) – Seeking Alpha
Novo Nordisk continues to slip after outlook cut, obesity drug worries (NVO:NYSE) Seeking Alpha Wegovy maker Novo’s profit warning triggers $70 billion share rout Reuters Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning The New York Times NVO Stock Crashes 22% After 2025 View Cut: More Downside Ahead? Yahoo Finance Health Care Roundup: Market Talk The Wall Street Journal Source link
Read More »